Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06513208
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-06-25
Brief Title:
Ketorolac Effects on Post-operative Pain and Lumbar Fusion
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Ketorolac Effects on Post-operative Pain and Lumbar Fusion a Double Blind Randomized Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A double blind prospective randomized trial of IV Ketorolac vs placebo in management of patients undergoing lumbar one or two level spinal fusions
Primary objective
- To demonstrate Ketorolac results in decreased postoperative opioid use following posterior spinal fusions during the first 48 hours
Secondary objectives
To demonstrate that the use of Ketorolac does not decrease spinal fusion in one or two level instrumented spinal fusions
To demonstrate the use of Ketorolac decreases the average length of stay following spinal fusions
Primary objective
- To demonstrate Ketorolac results in decreased postoperative opioid use following posterior spinal fusions during the first 48 hours
Secondary objectives
To demonstrate that the use of Ketorolac does not decrease spinal fusion in one or two level instrumented spinal fusions
To demonstrate the use of Ketorolac decreases the average length of stay following spinal fusions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None